Stock Ratios
Making an investment decision in the stock market involves a certain amount of risk, so it's important to thoroughly review a company's stock before making any decisions. Stock float, number of short positions and outstanding shares are among the many factors an investor should take into account.
profit margin TTM
-1787.93%
operating margin TTM
-3450.85%
revenue TTM
729
revenue per share TTM
0.0$
valuation ratios | |
|---|---|
| pe ratio | -0.03 |
| peg ratio | 0.01 |
| price to book ratio | -0.01 |
| price to sales ratio | 0.56 |
| enterprise value multiple | 1.27 |
| price fair value | -0.01 |
profitability ratios | |
|---|---|
| gross profit margin | 81.18% |
| operating profit margin | -3450.85% |
| pretax profit margin | -2025.62% |
| net profit margin | -1787.93% |
| return on assets | -217.44% |
| return on equity | 31.73% |
| return on capital employed | 57.37% |
liquidity ratio | |
|---|---|
| current ratio | 0.05 |
| quick ratio | 0.05 |
| cash ratio | 0.03 |
efficiency ratio | |
|---|---|
| days of inventory outstanding | 0.00 |
| operating cycle | 179.60 |
| days of payables outstanding | 7,603.43 |
| cash conversion cycle | -7,423.83 |
| receivables turnover | 2.03 |
| payables turnover | 0.05 |
| inventory turnover | 0.00 |
debt and solvency ratios | |
|---|---|
| debt ratio | 2.73 |
| debt equity ratio | -0.37 |
| long term debt to capitalization | -0.16 |
| total debt to capitalization | -0.59 |
| interest coverage | -8.31 |
| cash flow to debt ratio | -0.14 |
cash flow ratios | |
|---|---|
| free cash flow per share | -1.51 |
| cash per share | 0.87 |
| operating cash flow per share | -1.47 |
| free cash flow operating cash flow ratio | 1.02 |
| cash flow coverage ratios | -0.14 |
| short term coverage ratios | -0.22 |
| capital expenditure coverage ratio | -19.18 |
Frequently Asked Questions
When was the last time Biora Therapeutics, Inc. (NASDAQ:BIOR) reported earnings?
Biora Therapeutics, Inc. (BIOR) published its most recent earnings results on 14-11-2024.
What is Biora Therapeutics, Inc.'s current ROE?
An investor's main concern is the profitability ratios of a company so that they are able to understand how it performs financially. Investors are interested in finding out how effectively a business is using their cash to produce earnings, which is why return on equity (ROE) ratio is important. Biora Therapeutics, Inc. (NASDAQ:BIOR)'s trailing twelve months ROE is 31.73%.
What are ROA telling us?
The Return on Assets (ROA) ratio measures how profitable a company is relative to its total assets. Biora Therapeutics, Inc. (BIOR) currently has a ROA of -217.44%. Companies that manage their assets effectively will have greater returns, while those that do so poorly would suffer lower returns.
Where did BIOR's net profit margin stand at?
BIOR reported a profit margin of -1787.93% in the last quarter. A company's profit margin, also known as its revenue ratio or gross profit ratio, reflects the amount of revenue that an organization earns compared to its net income. In general, a higher ratio implies greater profit, and vice versa.
What is BIOR's short-term liquidity position?
Apple's current ratio, which measures its ability to pay short-term obligations, was 0.05 in the most recent quarter. The quick ratio stood at 0.05, with a Debt/Eq ratio of -0.37.